Abstract
The emerging role of interleukin-17 as a hallmark proinflammatory cytokine of the adaptive immune system produced by a new T helper cell subset termed “Th17” has received considerable attention. In this review we will focus on recent information regarding IL-17 and its relevance in autoimmune and chronic inflammatory diseases.
Similar content being viewed by others
References
Nalbandian A, Crispín JC, Tsokos GC (2009) Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol 157(2):209–215
Weaver CT, Hatton RD, Mangan PR, Harrington LE (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25:821–852
Korn T, Oukka M, Kuchroo VK, Bettelli E (2007) Th17 cells: effector cells with inflammatory properties. Semin Immunol 19:362–371
Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 cells. Annu Rev Immunol 27:485–517
Zenewicz LA, Antov A, Flavell RA (2009) CD4 T-cell differentiation and inflammatory bowel disease. Trends Mol Med 15(5):199–207
Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL (2003) Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278:1910–1914
Cosmi L, De Palma R, Santarlasci V, Maggi L, Capone M, Frosali F et al (2008) Human interleukin 17-producing cells originate from a CD161+ CD4+ T cell precursor. J Exp Med 205(8):1903–1916
Annunziato F, Romagnani S (2009) Do studies in humans better depict Th17 cells? Blood 114(11):2213–2219
Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F (2007) Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol l8(9):942–949
Manel N, Unutmaz D, Littman DR (2008) The differentiation of human Th17 cells requires transforming growth factor-beta and induction of the nuclear receptor ROR gamma t. Nat Immunol 9(6):641–649
Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hupé P, Barillot E et al (2008) A critical function for transforming growth factor-beta, interleukin-23 and proinflammatory cytokines in driving and modulating human Th17 responses. Nat Immunol 9(6):650–657
Yang L, Anderson DE, Baecher-Allan C, Hastings WD, Bettelli E, Oukka M et al (2008) IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 454(7202):350–352
Ouyang W, Kolls JK, Zheng Y (2008) The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28(4):454–467
Fenoglio D, Poggi A, Catellani S, Battaglia F, Ferrera A, Setti M et al (2009) Vdelta1 T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans. Blood 113(26):6611–6618
Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M et al (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203:2271–2279
Honda K, Takeda K (2009) Regulatory mechanisms of immune responses to intestinal bacteria. Mucosal Immunol 2(3):187–196
Nistala K, Adams S, Cambrook H, Ursu S, Olivito B, de Jager W et al (2010) Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci USA 107(33):14751–14756
Cosmi L, Maggi L, Santarlasci V, Capone M, Cardilicchia E, Frosali F et al (2010) Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. J Allergy Clin Immunol 125(1):222–230
Schwarzenberger P, Huang W, Ye P, Oliver P, Manuel M, Zhang Z et al (2000) Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J Immunol 164:4783–4789
Luger D, Silver PB, Tang J, Cua D, Chen Z, Iwakura Y et al (2008) Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 205(4):799–810
Kroenke MA, Carlson TJ, Andjelkovic AV, Segal BM (2008) IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med 205(7):1535–1541
Bending D, De La Peña H, Veldhoen M, Phillips JM, Uyttenhove C, Stockinger B et al (2009) Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Investig 119:565–572
Martin-Orozco N, Chung Y, Chang SH, Wang YH, Dong C (2009) Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur J Immunol 39(1):216–224
Miossec P (2009) IL-17 and Th17 cells in human inflammatory diseases. Microbes Infect 11(5):625–630
Kunz M, Ibrahim SM (2009) Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity. Mediators Inflamm 979258, pp 20
Ziolkowska M, Koc A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E, Chwalinska-Sadowska H et al (2000) High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol 164(5):2832–2838
Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y et al (2006) Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203:2673–2682
Andersson MK, Lundberg P, Ohlin A, Perry MJ, Lie A, Stark A et al (2007) Effects on osteoclast and osteoblast activities in cultured mouse calvarial bones by synovial fluids from patients with a loose joint prosthesis and from osteoarthritis patients. Arthritis Res Ther 9:R18
Kirkham BW, Lassere MN, Edmonds JP, Juhasz KM, Bird PA, Lee CS et al (2006) Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two year prospective study (the DAMAGE study cohort). Arthritis Rheum 54:1122–1131
Peck A, Mellins ED (2009) Breaking old paradigms: Th17 cells in autoimmune arthritis. Clin Immunol 132(3):295–304
Wiekowski MT, Leach MW, Evans EW, Sullivan L, Chen SC, Vassileva G et al (2001) Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. J Immunol 166:7563–7570
Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA et al (2003) Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198:1951–1957
Crispin JC, Kyttaris VC, Juang YT, Tsokos GC (2008) How signaling and gene transcription aberrations dictate the systemic lupus erythematosus T cell phenotype. Trends Immunol 29:110–115
Cohen RA, Bayliss G, Crispin JC, Kane-Wanger GF, Van Beek CA, Kyttaris VC et al (2008) T cells and in situ cryoglobulin deposition in the pathogenesis of lupus nephritis. Clin Immunol 128(1):1–7
Wong CK, Lit LC, Tam LS, Li EK, Wong PT, Lam CW (2008) Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol 127:385–393
Crispín JC, Oukka M, Bayliss G, Cohen RA, Van Beek CA, Stillman IE et al (2008) Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol 181(12):8761–8766
Zhang Z, Kyttaris VC, Tsokos GC (2009) The role of IL-23/IL-17 axis in lupus nephritis. J Immunol 183(5):3160316–3160319
Ludwig RJ, Herzog C, Rostock A, Ochsendorf FR, Zollner TM, Thaci D et al (2007) Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 156(2):271–276
Ortonne JP (2008) Psoriasis, metabolic syndrome and its components. Ann Dermatol Venereol 135(Suppl 4):S235–S242
Vaknin-Dembinsky A, Balashov K, Weiner HL (2006) IL-23 is increased in dendritic cells in multiple sclerosis and downregulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J Immunol 176(12):7768–7774
Bennett JL, Stüve O (2009) Update on inflammation, neurodegeneration, and immunoregulation in multiple sclerosis: therapeutic implications. Clin Neuropharmacol 32(3):121–132
Brand S (2009) Crohn’s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn’s disease. Gut 58(8):1152–1167
Yagi Y, Andoh A, Inatomi O, Tsujikawa T, Fujiyama Y (2007) Inflammatory responses induced by interleukin-17 family members in human colonic subepithelial myofibroblasts. J Gastroenterol 42:746–753
Izcue A, Hue S, Buonocore S, Arancibia-Cárcamo CV, Ahern PP, Iwakura Y et al (2008) Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity 28(4):559–570
Dambacher J, Beigel F, Zitzmann K, De Toni EN, Göke B, Diepolder HM et al (2009) The role of the novel Th17 cytokine IL-26 in intestinal inflammation. Gut 58(9):1207–1217
Ciprandi G, Filaci G, Battaglia F, Fenoglio D (2010) Peripheral Th-17 cells in allergic rhinitis: new evidence. Int Immunopharmacol 10(2):226–229
Robinson DS (2009) Regulatory T cells and asthma. Clin Exp Allergy 39(9):1314–1323
Lajoie S, Lewkowich IP, Suzuki Y, Clark JR, Sproles AA, Dienger K et al (2010) Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat Immunol 11(10):928–935
Romagnani S (2006) Immunological tolerance and autoimmunity. Intern Emerg Med 1(3):187–196
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Murdaca, G., Colombo, B.M. & Puppo, F. The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases. Intern Emerg Med 6, 487–495 (2011). https://doi.org/10.1007/s11739-011-0517-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-011-0517-7